2-178456101-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001042702.5(PJVK):c.499C>T(p.Arg167*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000998 in 1,613,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001042702.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000722 AC: 18AN: 249444Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135326
GnomAD4 exome AF: 0.0000999 AC: 146AN: 1461820Hom.: 0 Cov.: 31 AF XY: 0.0000908 AC XY: 66AN XY: 727204
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74316
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change creates a premature translational stop signal (p.Arg167*) in the DFNB59 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DFNB59 are known to be pathogenic (PMID: 17301963, 17718875). This variant is present in population databases (rs118203989, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with autosomal recessive deafness (PMID: 17373699). ClinVar contains an entry for this variant (Variation ID: 1300). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 11, 2024 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 22530481, 27018795, 35052489, 21696384, 28964305, 28483220, 26226137, 23804846, 17373699) - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 01, 2020 | The p.Arg167X variant in DFNB59 has been reported in 2 individuals with hearing loss (1 Turkish and 1 Iranian), and segregated with disease in at least 1 affected family member (Collin 2007, Akhtarkhavari 2014). All affected individuals were homozygous. This variant has been identified in 0.01% (18/128640) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This nonsense variant leads to a premature termination codon at position 167, which is predicted to lead to a truncated or absent protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hearing loss. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3, PP1_Supporting. - |
Autosomal recessive nonsyndromic hearing loss 59 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2007 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at